Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:08 AM
Ignite Modification Date:
2025-12-25 @ 3:08 AM
NCT ID:
NCT06030505
Eligibility Criteria:
Inclusion Criteria:
Cases :
* Children under 12 months of age
* Treated for acute RSV bronchiolitis
* Hospitalised following a visit to the paediatric emergency department
Controls :
* Children under 12 months
* Hospitalised in the conventional sector or in a short-stay hospital unit, or having consulted a paediatric emergency department for one of the following reasons
* Febrile urinary tract infection, without acute ear, nose, and throat (ENT) or respiratory symptoms
* Acute gastroenteritis, without acute ENT or respiratory symptoms
* Infant colic without fever, without ENT or acute respiratory symptoms
* Stagnant weight or feeding difficulties without fever, acute ENT or respiratory symptoms
* Neonatal jaundice without fever or acute ENT or respiratory symptoms
* Unexplained crying without fever, without ENT or acute respiratory symptoms
* Head injury, without acute ENT or respiratory symptoms
* Patient hospitalised for acute surgery without fever, without ENT or acute respiratory symptoms
Exclusion Criteria:
* Refusal to participate by the patient, their relative or legal representative
* Administration of Palivizumab.
* Maternal vaccination against RSV.
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
1 Year
Study:
NCT06030505
Study Brief:
Protocol Section:
NCT06030505